Pacific Biosciences' Q1 Net Loss Climbs as It Launches Sequencing Platform | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of the market Wednesday that its first-quarter net loss increased 15 percent year over year as the firm prepared for the commercial launch of its PacBio RS system, which it announced concurrently with its financials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.